Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polymeric micelle paclitaxel vs paclitaxel in HER2-negative recurrent/metastatic breast cancer
CTR20150197Phase 2Active
- Sponsor
- Shenzhen Tianyi Pharmaceutical Technology
- Start
- May 2015
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel polymeric micelle in breast cancer, sponsored by Shenzhen Tianyi Pharmaceutical Technology. Started May 2015; status: active.
02
Drugs
paclitaxel polymeric micelle
03
Conditions
breast cancer
Beyond the preview
Go deeper on CTR20150197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150197.